Health In Tech (NASDAQ:HIT) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Health In Tech (NASDAQ:HIT) announced its quarterly earnings data on Wednesday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. The company had revenue of $8.77 million for the quarter.

Here are the key takeaways from Health In Tech’s conference call:

• Health In Tech reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, implying roughly 35% to 50% year-over-year growth as the company continues to invest in expansion.
• First-quarter revenue was $8.8 million, up about 9% from last year, but adjusted EBITDA turned negative $1.3 million as spending increased on sales, marketing, and product development.
• The company introduced new reporting metrics: contracted revenue of about $22.9 million for the rest of 2026 and platform placed plan value of $82 million in Q1, which management said gives better visibility into future revenue.
• Management is stepping up investment in distribution, carrier partnerships, and AI-enabled technology, including a new AWS-related development effort and a more proactive broker go-to-market strategy.
• The company highlighted strong early interest in its three-year rate stabilization program and said it is on track for market testing later in 2Q into 3Q 2026, with no upfront deposit required from customers.

Health In Tech Stock Performance

Shares of NASDAQ:HIT traded down $0.17 during midday trading on Friday, reaching $1.06. 724,713 shares of the company’s stock traded hands, compared to its average volume of 289,813. The company has a market cap of $63.56 million, a price-to-earnings ratio of 53.00 and a beta of 3.67. Health In Tech has a one year low of $0.56 and a one year high of $4.02. The stock has a 50 day moving average of $1.58 and a 200 day moving average of $1.55.

Hedge Funds Weigh In On Health In Tech

Hedge funds have recently bought and sold shares of the business. Cubist Systematic Strategies LLC bought a new position in Health In Tech during the 1st quarter valued at about $41,000. Jane Street Group LLC bought a new stake in shares of Health In Tech in the first quarter worth approximately $48,000. Squarepoint Ops LLC purchased a new position in shares of Health In Tech during the third quarter valued at approximately $46,000. Two Sigma Investments LP purchased a new position in shares of Health In Tech during the third quarter valued at approximately $386,000. Finally, Raymond James Financial Inc. bought a new position in Health In Tech during the third quarter valued at approximately $45,000.

Wall Street Analyst Weigh In

HIT has been the topic of several recent analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Health In Tech in a research report on Thursday, April 2nd. Wall Street Zen cut shares of Health In Tech from a “hold” rating to a “sell” rating in a report on Saturday, April 25th. Finally, Craig Hallum initiated coverage on shares of Health In Tech in a research note on Monday, April 20th. They issued a “buy” rating and a $4.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $3.25.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.